ABC-lung: Atezolizumab, Bevacizumab and Chemotherapy in EGFR-mutant Non-small Cell Lung Carcinoma
Condition: EGFRmutant Stage IIIB/C or IV Non-squamous NSCLC Interventions: Drug: Atezolizumab; Drug: Bevacizumab; Drug: Carboplatin; Drug: Paclitaxel; Drug: Pemetrexed Sponsors: European Thoracic Oncology Platform; Roche Pharma AG Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Alimta | Avastin | Cancer & Oncology | Carcinoma | Chemotherapy | Non-Small Cell Lung Cancer | Research